Latest Asia Pacific News

Integrated Research’s FY26 results reveal a sharp 91% drop in net profit amid softer renewals and rising expenses, offset by a 27% jump in cash and a special dividend. The company pushes forward with AI-powered products despite early-stage commercialisation risks.

ParagonCare’s FY26 results show modest revenue and underlying earnings growth, overshadowed by a large credit loss provision related to the Infinity Pharmacy Group debt.

Ainsworth Game Technology’s first half 2026 results reveal a sharp revenue drop driven by North American and Latin American market pressures, offset partially by Asia Pacific growth and a key patent licensing deal.

Hiremii Limited posted an 8.6% revenue increase to $32.4 million and halved its net loss in FY26, reaching adjusted EBITDA breakeven as it prepares to rebrand as AQYR Limited.

HighCom Limited’s FY26 results reveal a sharp revenue drop and widening loss driven by a US Government shutdown, but a strengthened leadership team and expanded global sales pipeline set the stage for recovery.

International Graphite is advancing Australia’s first commercial graphite micronising plant at Collie, targeting commissioning by mid-2027. The facility promises a diverse range of superfine graphite products and potential annual EBITDA up to AUD 14.2 million based on current market conditions.

Jcurve Solutions (ASX:JCS) posted a significant financial turnaround in FY2026, with revenue climbing 16.3% to $13.28 million and normalised EBITDA more than doubling to $1.88 million, underpinned by disciplined cost control and recurring revenue growth.

Austin Engineering's FY26 results reveal a 12.7% revenue drop and a 53.7% EBITDA decline, driven by operational setbacks in the Americas and a loss-making Chile contract. Improved cash flow and safety metrics offer a silver lining as the company embarks on a reset for FY27.

SiteMinder Limited (ASX:SDR) nearly doubled its adjusted EBITDA to $28.1 million in FY26, driven by a 22% revenue increase and strong adoption of its AI-powered Smart Platform. The company narrowed its net loss by more than half amid ongoing investments in growth and operational efficiency.

Comms Group Limited reported record FY26 revenue and EBITDA growth, driven by organic expansion and TasmaNet acquisition, while progressing the $30m sale of its ICT business to streamline operations and support shareholder returns.

Pacific Edge’s draft Medicare Local Coverage Determination for its Cxbladder bladder cancer tests marks a pivotal step toward unlocking a $10.2 billion global market. Despite FY26 setbacks, the company is poised for growth with improved reimbursement prospects and strategic cost management.

IDT Australia reports a sharp turnaround in FY26 with a 66% reduction in net loss and an 85% improvement in EBITDA, underpinned by a strategic reset and targeted investments in manufacturing capabilities.